Frank D. Rodriguez is a shareholder of the firm and one of the founding members of the firm's burgeoning intellectual property practice. He has extensive litigation experience in a broad range of areas, including intellectual property, products liability, professional malpractice, and complex litigation. For nearly a decade he has concentrated his practice in the representation and counseling of pharmaceutical industry clients, specializing in litigating patent cases arising under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman cases), providing patent opinions, and conducting due diligence studies. He also provides strategic legal counsel on matters involving abbreviated new drug applications (ANDAs), section 505(b)(2) applications, and FDA regulatory and market exclusivity issues. Prior to his legal career, Mr. Rodriguez was a development scientist for both branded and generic pharmaceutical companies.